Healthcare Humanoid Robot Market size is estimated at USD 2.4 billion in 2024 and is estimated to reach USD 15.3 billion by the end of 2037, expanding at a CAGR of 16.7% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of healthcare humanoid robot is assessed at USD 2.8 billion.
Advancements in robotics and AI, increasing geriatric population, and rising demand for improved patient care, are key factors driving the global market growth. According to the WHO, the global population percentage aged 60 years old and above is projected to nearly double from 12% to 22%, between 2015 and 2050. Furthermore, the adoption of automation in hospitals for tasks including patient monitoring, rehabilitation, and surgery is also boosting the demand for these robots.
In addition, humanoid robots help enhance the quality of life for disabled people by providing physical assistance, support, and increased accessibility. As per a report published by the WHO in March 2023, 1.3 billion people, constituting 16% of the world’s total population experience some disability. It further states that most people with physical impairment face many health inequities, leading to 20 years pre-mature deaths than those without disabilities. These factors are further projected to drive healthcare humanoid robot market growth significantly as technology evolves and accessibility increases to meet the rising demands for robotic solutions for differently-abled people.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
16.7% |
|
Base Year Market Size (2024) |
USD 2.4 billion |
|
Forecast Year Market Size (2037) |
USD 15.3 billion |
|
Regional Scope |
|
Application (Companionship, Rehabilitation, Patient care and monitoring, Other applications)
In application, the companionship segment is projected to dominate the healthcare humanoid robot market, registering a share of 48.4% during the forecast period. The growth is driven the rising demand for emotional support and social interaction, particularly among elderly, disabled, and isolated patients. As mental issues become more prevalent, especially among the aged population, humanoid robots are being developed to provide companionship and offer cognitive stimulation. For instance, in December 2023, UBTECH Robotics partnered with the University of Hong Kong for collaborative research on human-like visual perception algorithms and technology for humanoid robots.
These robots are equipped with advanced AI to recognize emotions, respond empathetically, and interact socially, making them valuable in long-term care settings and for patients with dementia or other cognitive impairments. This application not only improves patient well-being but also reduces burden on the healthcare staff by addressing emotional and social needs. Factors including these are anticipated further drive the healthcare humanoid robot market, majorly for the healthcare companion robots, during the forecast period.
End use (Hospitals & clinics, Rehabilitation centers, Home healthcare, Other end-users)
In end use, hospitals & clinics segment is anticipated to register a considerable growth during the forecast period. The segment growth is driven by the need to enhance perational efficiency, reduce staff workloads, and improve patient care. The ability of robots to automate routine tasks allows healthcare professionals to focus on more critical medical functions, improving overall service delivery. In October 2023, King Faisal Specialist Hospital & Research Centre (KFSH&RC) introduced Nour R1. It is a humanoid robot designed to offer information and communication technology (ICT) services to enhance the experience for both employees and patients.
Furthermore, the rising demand for personalized rehabilitation therapies has led to the use of robots in physical therapy, helping patients recover more effectively with customized, data-driven exercises. Robots are also being used to assist in specialized areas such as pediatric care, providing comfort and engagement for young patients, and in infection control, reducing the risk of disease transmission, by performing non-contact tasks. These niche drivers cater to specific healthcare challenges, further expanding the scope of humanoid robot applications in clinical settings.
Our in-depth analysis of the healthcare humanoid robot market includes the following segments:
|
Component |
|
|
Application |
|
|
End use |
|
APAC Market Statistics
The APAC healthcare humanoid robot market is majorly driven by the rapidly aging population, and rising demand for advanced healthcare solutions. Countries such as Japan, South Korea, and China are at the forefront, with a string of government support and investments in healthcare innovation. The region is witnessing rising adoption of these robots in hospitals and elderly care facilities to address staff shortages, enhance patient care, and provide companionship. In June 2021, Hanson Robotics announced the launch of a new prototype Grace. The humanoid robot is developed targeting the healthcare market and designed mainly to interact with the elderly and people who were isolated by the COVID-19 pandemic.
South Korea market is driven by the strong technological infrastructure and government support for innovation in healthcare. The market is further supported by the country’s leadership in robotics and AI development, as well as its focus on smart hospitals and digital healthcare solutions, positioning South Korea as a key player in the healthcare robotics space. Moreover, the country focuses on improving mental healthcare and reducing healthcare worker burnout. Humanoid robots are being increasingly adopted in mental health facilities in the country to provide emotional support and companionship.
China healthcare humanoid robot market is driven by a combination of factors, including an aging population, rising demand for elderly care, and the government’s push for technological innovation. The China government also offers supportive policies for AI integration in healthcare. For instance, the Haidian district in China supports the application of AI and other new technologies in the field of pharmaceutical and health services, with a maximum financial support of USD 4.2 million. These factors are projected to further drive the market growth.
North America Market Analysis
The rising elderly population of North America demands daily activities, companionship, and medical support assistance. These healthcare humanoid robots market offer solutions for their care, lower isolation, and enhance the quality of living for older adults. The region also focuses highly on healthcare and smart home technologies integration, further driving the demand for robots that can interact effortlessly with supplementary devices and systems. Moreover, substantial funding from private investments and government policies and programs in robotics R&D activities encourages the growth of the market in the region.
The U.S. market is majorly driven by the need to manage the high healthcare costs and the shortage of medical professionals. The country’s favorable environment for startups fosters technological innovation. Furthermore, the adoption of robotic surgery assistants, AI-powered diagnostic tools, and companion robots for mental health which aim to enhance efficiency and reduce the burden on healthcare workers is boosting the market growth further. Rising demand for rehabilitation and personalized in-home care is also driving the U.S. market.
Canada healthcare humanoid robot market is witnessing an increasing prevalence of chronic diseases creating a demand for robotic solutions that can assist in patient monitoring, elderly care, and rehabilitation. Other drivers also include robotic systems for physical therapy, and AI-enhanced tools for mental health interventions, particularly in underserved communities. Companies are also making huge investments in the country to remain competitive in the Canada market. For instance, in July 2024, Sanctuary AI surpassed USD 140 million in total funding following its strategic investment from Canadian firms BDC Capital and InBC Investment Corp. The company plans to use the funds to accelerate the development of its AI-powered humanoid robots for multi-purposes.
Companies in the healthcare humanoid robot market are focusing on expansion strategies that include developing advanced AI capabilities, improving human-robot interaction, and enhancing robot versatility for various healthcare tasks. These firms are heavily investing in R&D activities to create robots that can offer more personalized care, perform complex medical tasks, and seamlessly integrate with hospital systems. In June 2024, Realbotix announced a strategic partnership with ROBOTIS INC. The agreement entitles Realbotix as an official partner for developing, facilitating collaboration and integration with ROBOTIS' advanced robotic components and systems.
Some of the prominent market players include:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?